Earlier evidence suggested that M2 muscarinic receptor antagonism may enhance memory due to their autoreceptor function, sparking interest as a potential treatment for cognitive disorders related to cholinergic dysfunction, such as AD (Rowe et al. 2003). This evidence concerns the gene CHRM2 and Alzheimer disease.